Income Tax Expense (Benefit) in USD of Orchard Therapeutics plc from 2016 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Orchard Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and change rate from 2016 to Q3 2023.
  • Orchard Therapeutics plc Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $976K.
  • Orchard Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2023 was -$140K, a 87.5% increase year-over-year.
  • Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was -$2.37M, a 387% decline from 2021.
  • Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $828K.
  • Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2020 was -$731K, a 67.4% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Orchard Therapeutics plc Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$140K $976K +$2.06M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$2.2M $25K +$244K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$2.44M -$12K -$70K -121% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$2.37M -$1.13M -$1.25M -1010% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 -$1.12M -$1.08M +$49K +4.33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.17M -$219K -$969K -129% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$201K $58K -$1.03M -94.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $828K $124K +$39K +45.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 $789K -$1.13M -$592K -109% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.38M $750K +$690K +1150% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $691K $1.09M +$1.42M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$731K $85K -$48K -36.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$683K -$541K +$1.65M +75.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$2.34M $60K +$832K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$3.17M -$335K -$928K -156% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$2.24M $133K -$269K -66.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$1.97M -$2.19M -$2.93M -399% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $956K -$772K -$690K -841% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.65M $593K +$676K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $970K $402K Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $733K Jul 1, 2018 Sep 30, 2018 6-K 2019-11-07
Q2 2018 -$82K Apr 1, 2018 Jun 30, 2018 6-K 2019-08-08
Q1 2018 -$83K Jan 1, 2018 Mar 31, 2018 6-K 2019-05-28

Orchard Therapeutics plc Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$2.37M -$3.2M -387% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 $828K +$1.56M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 -$731K +$1.51M +67.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$2.24M -$3.21M -331% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $970K +$917K +1730% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $53K +$33K +165% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $20K Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.